Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Collagen XVII promotes dormancy of colorectal cancer cells by activating mTORC2 signaling. | Cell Signal | 2024 | 38795810 | PubTator, text mining | PubMed |
| Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy. | Ann Hematol | 2024 | 38780802 | PubTator, text mining | PubMed |
| Collagen 17A1 in the Urothelium Regulates Epithelial Cell Integrity and Local Immunologic Responses in Obstructive Uropathy. | Am J Pathol | 2024 | 38768778 | PubTator, text mining | PubMed |
| Study of original B cells producing pathogenic IgG and IgA autoantibodies in anti-BP180-type mucous membrane pemphigoid. | Arch Dermatol Res | 2024 | 38734797 | PubTator, text mining | PubMed |
| Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells. | Commun Biol | 2024 | 38702433 | PubTator, text mining | PubMed |
| Potential correlation between anti-laminin 332 autoantibodies and malignant tumours in anti-BP180-type mucous membrane pemphigoid. | Clin Exp Dermatol | 2024 | 38634807 | PubTator, text mining | PubMed |
| Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations. | Cancers (Basel) | 2024 | 38610926 | PubTator, text mining | PubMed |
| Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity. | J Dermatol Sci | 2024 | 38582700 | PubTator, text mining | PubMed |
| Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation. | J Invest Dermatol | 2024 | 38522573 | PubTator, text mining | PubMed |
| Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein. | J Dermatol Sci | 2024 | 38508975 | PubTator, text mining | PubMed |
| A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody. | J Dermatol | 2024 | 38507442 | PubTator, text mining | PubMed |
| On- and off-target effects of paired CRISPR-Cas nickase in primary human cells. | Mol Ther | 2024 | 38459694 | PubTator, text mining | PubMed |
| The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls. | Dermatol Ther (Heidelb) | 2024 | 38451422 | PubTator, text mining | PubMed |
| Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment. | Biomed Pharmacother | 2024 | 38401525 | PubTator, text mining | PubMed |
| Oral mucous membrane pemphigoid: updates in diagnosis and management. | Br Dent J | 2024 | 38388600 | PubTator, text mining | PubMed |
| IC3D Classification of Corneal Dystrophies-Edition 3. | Cornea | 2024 | 38359414 | PubTator, text mining | PubMed |
| Expression of Serum Anti-BP180/230 Antibodies in Bullous Pemphigoid Patients Combined with Nervous System Diseases and Relevant Factor Analysis. | J Coll Physicians Surg Pak | 2024 | 38342861 | PubTator, text mining | PubMed |
| Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions. | J Allergy Clin Immunol Glob | 2024 | 38317805 | PubTator, text mining | PubMed |
| The Syk Inhibitor Entospletinib Abolishes Dermal-Epidermal Separation in a Fully Human Ex Vivo Model of Bullous Pemphigoid. | J Invest Dermatol | 2024 | 38296021 | PubTator, text mining | PubMed |
| Bullous pemphigoid with prominent mucosal involvement in the setting of renal allograft rejection. | JAAD Case Rep | 2024 | 38292570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=13